COVID-19 has demonstrated how vital vaccines are to citizens throughout the world. Since the outbreak of the COVID-19 pandemic, scientists around the world have been working constantly to find a vaccine to protect people against this disease. In previous times, vaccines weren’t even an option; they were only first developed in the eighteenth century. The first vaccine was introduced in 1796 by Edward Jenner and was used to protect against smallpox (Children’s Hospital of Philadelphia). Vaccines are used for dozens of diseases in order to prevent widespread pandemics, like the one we are living through today. I argue that there are substantial differences regarding vaccines in underdeveloped versus developed countries.
Underdeveloped countries have less access to vaccines, while developed countries are able to create laws mandating vaccine usage. Moreover, I demonstrate that globalization has had a large impact on the usage of vaccines, as travel, migration, and trade have impacted the global structure. Lastly, I discuss the necessity of vaccines, and why they are safer than the disease itself. Vaccines are essential to the international political economy of everyday life, as they are vital to saving lives.
Vaccines are used for a wide range of diseases. These include diseases like Rubella, that is spread by coughing and sneezing, HPV, which is spread through vaginal, anal, or oral sex, Polio, which can be spread through stool (feces), sneezing, or coughing (CDC), and dozens of more diseases that can be spread in a number of different ways. Common vaccines used across developed countries today are the MMR (Measles, Mumps, and Rubella), the polio vaccine (IPV), and the chickenpox vaccine (varicells).The proliferation of vaccines and access to them was expanded by the "Expanded Programme on Immunization" that was introduced in 1974. Since the program was introduced, children's vaccinations increased from 15 to 90 percent. These vaccines are now often required for children entering schools and other programs. Moreover, these vaccines have improved the survival rate of children through their effectiveness. For example, the MMR vaccine--which prevents measles, mumps and rubella, has a 97 percent effective rate. Furthermore, the vaccine for Polio is almost 100 percent effective after three doses. In general, the adoption of vaccination/immunization as a practice has improved life expectancy.
While the goal of vaccines is to eradicate dangerous diseases and to protect people across the world, the citizens of many countries cannot access or afford them. This creates an inherent inequality among citizens of the world. Countries with lower levels of development, or LDCs, have higher rates of disease and are often more prone to pandemics (New England Journal of Medicine). More developed countries that have higher levels of wealth are often the ones who can afford to research and manufacture vaccines, leading to their proliferation and development among developed nations. The New England Journal of Medicine states that “If a 1918-like pandemic were to occur today, tens of millions of people could die, the vast majority of them in the world’s poorest countries.” Because LDC’s have underdeveloped health systems, they do not have enough ways to test and treat the disease. The UN states that “LDCs lack not only the necessary testing capacities, but the technologies and governance structures to effectively and efficiently trace and isolate the infected” (UN). Less developed countries do not have the ability to test and collect accurate information, leading to further spread of illness and death.
Another benefit that developed countries hold over less developed countries is they make vaccines mandatory. Many developed countries require students who enter public school and sometimes private school and day care facilities, to have certain vaccinations. In the United States, for example, “state laws establish vaccination requirements for school children” (CDC). Mandatory vaccines are used as a “prerequisite to public school enrollment because it is the most efficient method of perpetuating herd immunity” (National Center for Biotechnology Information). Herd immunity is when a large portion of the community is immune to a disease (either through vaccination or previous illness). Individuals who are unable to get vaccinated due to health circumstances/ are immunocompromised are offered protection from this disease because the disease does not have a chance to spread throughout the community. Herd immunity is therefore necessary to protect the weaker members of the community who cannot get vaccinated and are more vulnerable to these diseases. Mandatory vaccination allows those who enter into the school system to be protected from a variety of diseases, ensuring the safety of students, teachers, and staff. However, due to the lack of a developed governmental structure, low incomes, and low levels of infrastructure, many countries, specifically those in Africa, do not have access to these vaccines. Developed countries have an unfair advantage because they are able to produce, distribute, and regulate these vaccines, preventing life threatening illnesses. Less developed countries need improvements in science, infrastructure, and laws in order to access life-saving vaccines.
Globalization plays two vital roles in vaccination. Because of new transportation methods, people are able to travel, migrate, and trade across the world. Instead of previous diseases that were confined to one space/ country, they are now able to spread worldwide (as we are now seeing with Covid-19). Vaccines are necessary to stop the spread and/ or prevent illnesses from moving across the globe. In 2005, International Health Regulations revised how countries would report outbreaks, share information regarding diseases, the vaccine research, deal with outbreaks, and minimize travel and trade outside the infected zone (Balaam). While globalization may allow for the more rapid spread of illness, it also has its benefits. For example, globalization allows academics and medical researchers in developed countries to travel to less developed countries and use their education and skills to develop vaccines there. Moreover, it allows the transfer of education from the researchers and specialists to people who live in less developed countries (Milstien). Globalization makes vaccines a necessity for all countries, as illnesses have no limits thanks to travel, migration, and trade. Globalization also allows for researchers and development to flow from a developed country to a less developed country.
There need to be many reforms made so that vaccines can be introduced in developing countries. The first reform that must be made is in terms of markets, as “market forces do not always serve low- income countries well” (GAVI). The lack of markets within developing countries is a major factor influencing research and development. Before creating new vaccines and medicines, pharmaceutical companies need to be certain they will see a return on their investments in research and development.
Moreover, developing countries need to strengthen their intellectual property laws because if they don’t, then pharmaceutical companies won’t want to create vaccines there, as they have no protection (Milstien). Patents protect economic incentives relating to exclusivity and monopolies (Martens). Pharmaceutical companies will not want to move/ set up their business in places without strong intellectual property laws because their products can be easily stolen. Strong intellectual property laws encourage innovation because it benefits research and science companies by rewarding them with a monopoly, and in turn, large profits.
On top of this, developing nations need to increase the number of academic institutions committed to researching diseases and vaccines, the manufacturing process needs to be improved and accelerated, the number of safe clinical trials needs to be increased, and the public must be knowledgeable about vaccines before its introduction (Greenwood).
Vaccines are an essential component to the international political economy of everyday life. Vaccines serve the purpose of preventing and treating dangerous diseases that may lead to worldwide pandemics. Since the first vaccine was invented in 1796, millions of lives have been saved and millions of illnesses have been prevented, with some vaccines even having a 99-100% effectiveness rate. Unfortunately there are differences between less developed and developed countries that must be fixed in order for vaccines to be accessible to all global citizens. Moreover, globalization has made vaccination a necessity due to all the traveling, migration, and trade that takes place. On top of all of this, vaccinations are incredibly safe- safer than the diseases they prevent and protect against, which is why they need to be internationally accessible. Vaccination has played a vital role in the international political economy since its creation, and it’s still incredibly important to this day.
“Autism.” Centers for Disease Control and Prevention , 2020, www.cdc.gov/vaccinesafety/concerns/autism.html.
Balaam, David N, and Bradford Dillman. Introduction to International Political Economy . 7th ed., Routledge, 2019.
Ciolli, Anthony. “Mandatory School Vaccinations: The Role of Tort Law.” Yale Journal of Biology and Medicine , 2008, www.ncbi.nlm.nih.gov/pmc/articles/PMC2553651/.
Greenwood, Brian, et al. “Vaccines and Global Health.” Philosophical Transactions of the Royal Society B , 2011, royalsocietypublishing.org/doi/10.1098/rstb.2011.0076.
“Herd Immunity.” Association for Professionals in Infection Control and Epidemiology , apic.org/monthly_alerts/herd-immunity/.
“HPV (Human Papillomavirus).” Centers for Disease Control and Prevention , 2019, www.cdc.gov/vaccines/parents/diseases/hpv.html.
“Immunization Campaigns.” American Academy of Pediatrics , www.aap.org/en-us/about-the-aap/aap-press-room/campaigns/Pages/NIIW.aspx.
Kluger, Jeffrey. “A Vaccine Against COVID-19 Would Be the Latest Success in a Long Scientific History.” Time , 2020, time.com/5835668/vaccine-history/.
“Market Shaping.” GAVI, the Vaccine Alliance , www.gavi.org/our-alliance/market-shaping.
“Measles.” Centers for Disease Control and Prevention , 2019, www.cdc.gov/vaccines/vpd/measles/index.html.
Milstien, Julie, and Miloud Kaddar. “Managing the Effect of TRIPS on Availability of Priority Vaccines.” Scientific Electronic Library Online , 2006,
www.scielosp.org/article/bwho/2006.v84n5/360-365/en/.
“Polio Vaccine Effectiveness and Duration of Protection.” Centers for Disease Control and Prevention , 2018,
www.cdc.gov/vaccines/vpd/polio/hcp/effectiveness-duration-protection.html.
“Polio.” Centers for Disease Control and Prevention , 2019, www.cdc.gov/vaccines/parents/diseases/polio.html.
Raman, Radhika, and Knobbe Martens. “Economic and IP Considerations in Developing and Distributing a COVID 19 Vaccine.” JD Spura , 2020,
www.jdsupra.com/legalnews/economic-and-ip-considerations-in-73589/.
“Six Common Misconceptions About Immunization.” World Health Organization , www.who.int/vaccine_safety/initiative/detection/immunization_misconceptions/en/index4.html.
“State Vaccination Requirements.” Centers for Disease Control and Prevention , 2016, www.cdc.gov/vaccines/imz-managers/laws/state-reqs.html.
Stellino, Molly. “Fact Check: Herd Immunity Would Not Fully Stop the Spread of Coronavirus.” Daily News Journal , 2020,
www.dnj.com/story/news/factcheck/2020/04/18/fact-check-herd-immunity-would-not-fullystop-spread-coronavirus/5156368002/.
Thompson, Dennis. “The Salk Polio Vaccine: ‘Greatest Public Health Experiment in History.’” CBS News , 2014, www.cbsnews.com/news/the-salk-polio-vaccine-greatest-public-health-experiment-in-history/.
“UN/DESA Policy Brief #66: COVID-19 and the Least Developed Countries.” United Nations, 2020, www.un.org/development/desa/dpad/publication/un-desa-policy-brief-66-covid-19-and-the-least-developed-countries/.
“Vaccine Design and Delivery Research Group (Burkhart Lab).” University of Montana, health.umt.edu/biomed/labs/vaccine-research-group/.
“Vaccine History: Developments by Year.” Children's Hospital of Philadelphia,www.chop.edu/centers-programs/vaccine-education-center/vaccine-history/developments-by-year.
Yamada, Tadataka. “Poverty, Wealth, and Access to Pandemic Influenza Vaccines.” The New England Journal of Medicine , 2009, www.nejm.org/doi/full/10.1056/nejmp0906972.